Lv3
400 积分 2025-09-16 加入
Projected Trends in Metabolic Dysfunction–Associated Steatotic Liver Disease Mortality Through 2040
21天前
已完结
Unhealthy lifestyle habits and physical inactivity among Asian patients with non‐alcoholic fatty liver disease
21天前
已完结
MAFLD fibrosis score: Using routine measures to identify advanced fibrosis in metabolic‐associated fatty liver disease
21天前
已完结
Trends in risk factor control and treatment among patients with non‐alcoholic fatty liver disease and type 2 diabetes between 2000 and 2020: A territory‐wide study
21天前
已完结
Angiotensin‐converting enzyme inhibitors prevent liver‐related events in nonalcoholic fatty liver disease
21天前
已完结
Risk of liver‐related events by age and diabetes duration in patients with diabetes and nonalcoholic fatty liver disease
21天前
已完结
Duration of type 2 diabetes and liver-related events in nonalcoholic fatty liver disease: A landmark analysis
21天前
已完结
Disease Progression for Histologic Diagnosis of Metabolic Dysfunction-Associated Steatotic Liver Disease in the Real-World: A Nationwide US Study
21天前
已完结
Enhanced long-term outcomes with laparoscopic bariatric surgery in patients with severe obesity and metabolic dysfunction-associated steatotic liver disease: a retrospective cohort study
21天前
已完结
Metabolic dysfunction-associated steatotic liver disease: A sexually dimorphic disease and breast and gynecological cancer
21天前
已完结
皖公网安备34019202002308
